Cite
APA Citation
Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (n.d.). safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet neurology, 16(6), 425–434. http://access.bl.uk/ark:/81055/vdc_100046148091.0x000041